Mirae Asset Healthcare Fund Regular Growth
Medium
Risk
Equity
Other
+
18.44
%
18.44
%
3Y annualised
+
0.36
%
0.36
%
1D
1M
6M
1Y
3Y
All
Fund size
2161
NAV:
Mar 7, 2024
30.894
Sector
Tech
Type
Equity
Launched
Jun 2018
Min Investment
5000
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
16.03
%
Cipla Ltd
8.98
%
Aurobindo Pharma Ltd
8.64
%
Dr Reddy's Laboratories Ltd
8
%
Apollo Hospitals Enterprise Ltd
6.55
%
Krishna Institute of Medical Sciences Ltd
5.53
%
J.B. Chemicals & Pharmaceuticals Ltd
4.92
%
Torrent Pharmaceuticals Ltd
4.05
%
Lupin Ltd
4.04
%
Gland Pharma Ltd
3.9
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 1.0% if redeemed within 365.0 Days, 0.0 % if redeemed after 365.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
Mirae Asset Healthcare Fund Regular Growth
More details
Investment objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
